Jeevan Scientific successfully completes USFDA audit with zero observations

13 Jun 2017 Evaluate

Jeevan Scientific Technology (JST) has completed the audit conducted by USFDA at its corporate and clinical pharmacology centre facilities. No 483 observations were issued to the company.

The US Food and Drug Administration (USFDA) had conducted an un-announced audit at the company’s corporate and clinical pharmacology centre facilities. The purpose of this audit was to review the BA/BE studies. The auditor started the review on Jun 05, 2017 and completed on Jun 08, 2017.

Jeevan Scientific Technology provides a range of clinical research services for healthcare/pharmaceutical industries in India and internationally. Its clinical research services comprise bio-analytical, clinical data management, biostatistics and statistical programming, medical writing, pharmacovigilance, regulatory affairs, quality assurance, and project management services, as well as clinical operation and scientific writing services.



Jeevan Scientific Share Price

61.70 0.70 (1.15%)
Jul 06, 18:01 View Price Chart
Peers
Company Name CMP
TCS 3260.30
Infosys 1491.95
Wipro 416.10
HCL Tech. 986.65
Tech Mahindra 1010.50
View more..